Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 DKK)

NET PROFIT (x1000 DKK)

EMPLOYEES

Share

Eql Pharma AB

Closing information (x1000 DKK)

Closing information 2025/03 (consolidated) 2024/03 (consolidated) 2023/03 (consolidated)
Turnover 256,882 Less Arrow 170,947 More Arrow 171,696
Financial expenses 8,956 Less Arrow 3,709 Less Arrow 1,567
Earnings before taxes 37,381 Less Arrow 18,510 More Arrow 25,742
EBITDA 55,047 Less Arrow 26,774 More Arrow 32,782
Total assets 556,261 Less Arrow 241,865 Less Arrow 188,728
Current assets 275,270 Less Arrow 127,983 Less Arrow 110,469
Current liabilities 152,003 Less Arrow 104,865 Less Arrow 76,612
Equity capital 152,015 Less Arrow 115,009 Less Arrow 102,228
- share capital 900 Less Arrow 846 More Arrow 864
Employees (average) 21 Equal arrow 21 Less Arrow 18

Financial ratios

Fiscal year 2025/03 (consolidated) 2024/03 (consolidated) 2023/03 (consolidated)
Solvency 27.3% More Arrow 47.6% More Arrow 54.2%
Turnover per employee 12,232 Less Arrow 8,140 More Arrow 9,539
Profit as a percentage of turnover 14.6% Less Arrow 10.8% More Arrow 15.0%
Return on assets (ROA) 8.3% More Arrow 9.2% More Arrow 14.5%
Current ratio 181.1% Less Arrow 122.0% More Arrow 144.2%
Return on equity (ROE) 24.6% Less Arrow 16.1% More Arrow 25.2%
Change turnover 75,203 Less Arrow 2,753 Less Arrow -98,983
Change turnover % 41% Less Arrow 2% Less Arrow -37%
Chg. No. of employees 0 More Arrow 3 More Arrow 5
Chg. No. of employees % 0% More Arrow 17% More Arrow 38%

Total value of public sale

Fiscal year 2025/03 (consolidated) 2024/03 (consolidated) 2023/03 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.